Clinical Trials on Relapse Remitting Multiple Sclerosis in Australia
Total 192 results
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
Novartis PharmaceuticalsTerminatedRelapsing Remitting Multiple Sclerosis (RRMS)Germany, Spain, Australia, Israel, Switzerland, Italy, Austria, Greece, Hungary, Czech Republic, Finland
-
BiogenTerminatedRelapsing Remitting Multiple SclerosisAustralia
-
BiogenCompletedFatigue | Relapsing-Remitting Multiple SclerosisSweden, Norway, Austria, Denmark
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisUnited States, Spain, Germany, Australia, Sweden, Czechia, France, Italy, United Kingdom
-
Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisGermany, Estonia, Latvia, Lithuania, Finland, Austria, Denmark, Netherlands, Portugal, Switzerland, Norway, Italy
-
EMD Serono Research & Development Institute, Inc.CompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Bulgaria, France, Italy, Russian Federation, Turkey, United Kingdom, Estonia, Germany, Latvia, Lithuania, Poland, Austria, Brazil, Canada, Finland, Portugal, Greece, Serbia, Denmark, Ukraine, Saudi Arabia, Lebanon and more
-
Hoffmann-La RochePPDRecruitingRelapsing-Remitting Multiple SclerosisUnited States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Argentina, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisFinland, Germany, Spain, Belgium, Italy, Canada, France, New Zealand, Israel, Hungary, Greece, Australia, Netherlands, United Kingdom, Denmark, Ireland, Sweden, Poland, Czech Republic, Switzerland, Turkey
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Czech Republic, France, Italy, Mexico, South Africa, United Kingdom, Germany, Poland, Romania, Ukraine, Netherlands, Austria, Canada, Israel, New Zealand, Slovakia, Greece, Serbia, India, Belgium, Switzerland, ... and more
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisSpain, Australia
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, France, Germany, Spain, Belgium, Czechia, Switzerland, United Kingdom, Austria, New Zealand, Australia, South Africa, Ukraine, Italy, Slovakia, Greece, Poland, Israel, Netherlands, Bulgaria, Serbia, India, Romania, Estonia and more
-
BiogenAbbVieTerminatedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States, Denmark, Italy, United Kingdom, Czechia, Canada, Hungary, Spain, Australia, Israel, Georgia, Serbia, Russian Federation, Ukraine, India, Poland, Brazil, France, Argentina, Germany, Greece, Ireland, Mexico, Moldova, Republic... and more
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisBelgium, Germany, Italy, Norway, France, Mexico, Australia, Spain, Portugal, Greece, Netherlands, United Kingdom, Czechia, Slovakia, Finland, Canada, Argentina, Brazil
-
GlaxoSmithKlineCompletedMultiple SclerosisItaly, Germany, Spain, United Kingdom, Australia, Netherlands, New Zealand, Russian Federation, France, Canada, Austria, Poland, Finland, Norway
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
NovartisCompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)Relapsing-remitting Multiple SclerosisCanada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisFrance, Italy, Spain, Czechia, Hungary, Austria, Belgium, Canada, Portugal, Slovakia, Slovenia
-
BayerCompletedMultiple Sclerosis, Relapsing RemittingBelgium, Bosnia and Herzegovina, Italy, Austria, Croatia, Czechia, France, Greece, Hungary, Spain, Switzerland
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
BiogenElan PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisUnited States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
NovartisCompletedMultiple SclerosisUnited States, Turkey, Romania, United Kingdom, Poland, Austria, Canada, Australia
-
NovartisCompletedMultiple SclerosisGreece, Russian Federation, Switzerland, Germany, Israel, Ireland, Belgium, Finland, United Kingdom, Netherlands, Canada, Romania, Hungary, Poland, Czech Republic, Australia, Estonia, France, Slovakia, South Africa, Sweden, Turkey
-
ActelionCompletedMultiple SclerosisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Romania, Russian Federation, Serbia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czechia, Denmark, Germany, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, Spain, Sweden, Ukraine, United Kingdom
-
BiogenCompletedMultiple SclerosisUnited States, Italy, Hungary, United Kingdom, Spain, France, Australia, Germany, Canada, Switzerland, Argentina, Czech Republic, Croatia
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Argentina, Austria, Belgium, Croatia, Finland, France, Germany, Ireland, Italy, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Turkey
-
ActelionCompletedMultiple SclerosisPoland, Ukraine, United Kingdom, United States, Germany, Spain, Bulgaria, Romania, Serbia, Canada, Finland, Sweden, Russian Federation, Hungary, Czechia, Netherlands, Israel, Switzerland, Austria, France
-
NovartisCompletedMultiple SclerosisUnited States, Korea, Republic of, Portugal, Canada, Hungary, Spain, Germany, United Kingdom, Australia, Argentina, Austria, Belgium, Brazil, Egypt, France, Greece, Italy, Switzerland
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czechia, Estonia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Korea, Republic of, Latvia, Moldova, Republic of, Montenegro, North Macedonia and more
-
Clene NanomedicineClene Australia Pty LtdTerminatedRelapsing Remitting Multiple Sclerosis | Optic Neuropathy | Optic; Neuritis, With DemyelinationUnited States, Canada, Australia
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Spain, Canada, Australia, Germany, Italy, United Kingdom, Belgium, Netherlands, France, Israel
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, France, United States, Germany, Canada, United Kingdom, Russian Federation, Argentina, Brazil, Croatia, Poland, Serbia, Sweden, Ukraine, Czech Republic, Mexico
-
Grifols Therapeutics LLCCompletedMultiple Sclerosis, Relapsing-RemittingCanada, Israel, United States, Austria, Czech Republic, Germany, Greece, Hungary, Poland, Slovakia, Sweden, United Kingdom
-
Medical University of ViennaRecruitingMultiple Sclerosis, Relapsing-Remitting | Optic NeuritisAustria
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, Israel, United States, Canada, France, Switzerland, Ireland, Italy, Australia, Spain, Austria, Germany, Brazil, Netherlands, Poland, Russian Federation, Hungary, Slovenia, Argentina, Ukraine, Greece, Sweden, Finland, Latvia, No... and more
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, Israel, Sweden, United States, France, Switzerland, Ireland, Canada, Australia, Brazil, Austria, Poland, Germany, Hungary, Netherlands, Russian Federation, Spain, Argentina, Slovenia, Greece, Finland, Denmark, Ukraine, Italy, L... and more
-
BiogenRecruitingMultiple Sclerosis, Relapsing-RemittingSpain, Germany, Croatia, Turkey, Saudi Arabia, Hungary, Belgium, Australia, France, Portugal, Slovakia, United States, Bulgaria, Greece, Kuwait, Russian Federation, Tunisia, Italy, Argentina, Czechia, Israel, Serbia
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingNetherlands, Spain, Germany, Israel, United Kingdom, Canada, Australia, United States, Italy, Argentina, Croatia, Russian Federation, Poland, Czechia, Belgium, France, Brazil, Austria, Denmark, Mexico, Serbia, Sweden, Ukraine
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, United Kingdom, Australia, Belgium, Brazil, Croatia, France, Canada, Slovakia, Germany, Netherlands, Norway, Italy, Poland, Switzerland, Romania, Bulgaria, Spain, Mexico, Austria, Portugal, Turkey, Sweden, Argentina, Denmark and more
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, Denmark, Canada, United States, Netherlands, Argentina, Austria, Belgium, Brazil, Croatia, Czech Republic, France, Germany, Israel, Italy, Mexico, Poland, Russian Federation, Serbia, Spain, Sweden, Ukraine, United Kingdom
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, United Kingdom, Australia, Netherlands, Ireland, Norway, Turkey, Estonia, Denmark, Germany, Italy, Spain, Switzerland, France, Finland, Sweden, Czechia
-
SanofiTerminatedMultiple Sclerosis RelapseSpain, Germany, Sweden, Canada, Austria, Korea, Republic of, Russian Federation, Greece, Hungary, Italy, Belgium, Slovakia, Tunisia, France, Australia, United States, Argentina, Brazil, Chile, Colombia, Denmark, Estonia, Finland, Lith... and more
-
BiogenElan PharmaceuticalsCompletedSafety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingUnited States, Germany, Austria, Belgium, France, Israel, Italy
-
Innate ImmunotherapeuticsSyneos HealthCompletedSecondary Progressive Multiple SclerosisNew Zealand, Australia
-
Novartis PharmaceuticalsCompletedMayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGoSecondary Progressive Multiple SclerosisAustralia